A new generation ultra-long-acting insulin analogue-insulin degludec

Patients with diabetes usually require long-term insulin medication.Hypoglycemia,weight gain and cancer risk induced by insulin medication are the factors that should be considered in the selection of insulin medication protocols.Being a basal insulin,insulin degludec is a brand-new ultra-long-acting insulin analogue.With unique advantages of stable and slow release,sustained acting time,minor absorption variability,low incidence of hypoglycemia,flexible dosage,good control of high blood glucose and low incidence of nocturnal hypoglycemia,insulin degludec offers a new choice for insulin therapy of diabetes patients.